Special Interview with Dr. Naranjan S. Dhalla, Editorial Board Member of The Journal of Cardiovascular Aging
On July 19th, 2024, The Journal of Cardiovascular Aging (JCA) had the honor of interviewing Dr. Naranjan S. Dhalla, our Senior Advisory Editor. Dr. Dhalla is Distinguished Professor of Physiology and Pathophysiology at the Max Rady College of Medicine at the University of Manitoba. He is also a founding leader of two prominent global cardiovascular science organizations: the International Society of Heart Research (ISHR), which is devoted to basic cardiovascular science research, and the International Academy of Cardiovascular Sciences (IACS), which promotes cardiovascular health education and community involvement. In April 2021, Dr. Dhalla joined our Editorial Board due to his appreciation for JCA’s contributions to research on aging-related cardiovascular diseases.
During the interview, Dr. Naranjan S. Dhalla discussed a pivotal moment in his career that profoundly influenced his trajectory in cardiovascular research. He also outlined the significant challenges he encountered while establishing and leading renowned cardiovascular research institutions and shared how he addressed these challenges to advance scientific excellence and innovation.
Dr. Dhalla also shared his perspectives on the current challenges and emerging opportunities in cardiovascular research, as well as insights into hot topics in cardiovascular aging research.
In his advice to young scholars interested in cardiovascular research, Dr. Dhalla emphasized the importance of dedication and passion, as well as the values of sacrifice, honesty, and integrity in the pursuit of truth and scientific discovery.
Introduction to Dr. Naranjan S. Dhalla
Dr. Naranjan S. Dhalla is the Honorary Life President of the IACS and serves as Distinguished Professor at the University of Manitoba and Director of Cardiovascular Developments at the St. Boniface Hospital Albrechtsen Centre in Winnipeg, Manitoba, Canada. His Cardiology Laboratory focuses on studying the pathophysiology and pharmacotherapy of congestive heart failure, ischemia-reperfusion injury, and diabetes-induced cardiomyopathy.
Editor: Yuan Li
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of The Journal of Cardiovascular Aging
